Proteona

Proteona, a precision medicine company based in Singapore, Germany, and the United States, is a pioneer in using single-cell proteogenomics to improve cancer clinical outcomes. Proteona combines innovative single-cell multi-omics analysis technology with AI-assisted bioinformatics to provide users with end-to-end solutions from sample to answer, enabling them to perform cell phenotyping using standard protein markers and gain deeper insights into cell function based on gene expression profiles.